Medigus Ltd. Series C Warrant
MDGSW
MDGSW was delisted on the 19th of July, 2023.
5 hedge funds and large institutions have $10.3K invested in Medigus Ltd. Series C Warrant in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
25% more funds holding
Funds holding: 4 → 5 (+1)
1% more capital invested
Capital invested by funds: $10.2K → $10.3K (+$121)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Skaana Management
Brooklyn,
New York
|
+$4.22K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$742 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$5.91K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$139 |
MDGSW Hedge Fund Activity: Q2 2023 in Review
5 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Medigus Ltd. Series C Warrant (MDGSW) for Q2 2023, worth a combined $10.3K — up 1.2% from $10.2K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new MDGSW positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Skaana Management, opening a new position worth an estimated $4.22K. The largest seller was Anson Funds Management, exiting entirely with an estimated $5.91K sold.
- 5 institutional investors held Medigus Ltd. Series C Warrant (MDGSW) as of Q2 2023, up from 4 in Q1 2023.
- Funds reported $10.3K of Medigus Ltd. Series C Warrant stock for Q2 2023, up 1.2% quarter-over-quarter.
- 2 funds opened new Medigus Ltd. Series C Warrant positions in Q2 2023 and 1 closed out, a net change of +1 holder.
- The largest Medigus Ltd. Series C Warrant buyer in Q2 2023 was Skaana Management, an estimated $4.22K added.
- The largest Medigus Ltd. Series C Warrant seller in Q2 2023 was Anson Funds Management, an estimated $5.91K sold.
Based on aggregated 13F filings for Q2 2023.